Page 169 - SRPSKO DRUŠTVO ISTRAŽIVAČA RAKA
P. 169

SDIRSACR                                                                                 Oncology Insights





            SESSION 12

        TOXIC TRIGGERS: ENVIROMENTAL CHEMICALS AND CANCER RISK







        P82

        Protective Role of Mangiferin Against Bisphenol A-Induced Toxicity

        Ayca Uvez , Emel Durak , Sima Kilic3, Konstantinos Dimas , Elif Ilkay Armutak 1
                 1
                             2
                                                          4
        1Department of Histology and Embryology, Faculty of Veterinary Medicine, Istanbul University- Cerrahpasa, Istanbul, Turkey,
        34320, Istanbul, Turkey
        2 Institute of Graduate Studies, Istanbul University- Cerrahpasa, Istanbul, Turkey, 34320, Istanbul, Turkey
        3Institute of Nanotechnology and Biotechnology, Department of Biotechnology Istanbul University- Cerrahpasa 34320, Istanbul,
        Turkey
        4Department of Pharmacology, Faculty of Medicine, University of Thessaly, Larissa, Greece

        Keywords: Bisphenol A, Mangiferin, Protective effect, Endocrine-disruptor, HUVEC


        Background:  Bisphenol  A  (BPA),  a  widely  used  industrial  compound,  is  recognized  for  its  endocrine-disrupting
        potential and its detrimental effects on multiple organ systems, including the reproductive, neurological, hepatic,
        and cardiovascular systems. Chronic exposure to BPA, even at low doses, has been associated with oxidative stress,
        inflammation, and metabolic dysfunction. Mangiferin, a natural xanthone glycoside primarily isolated from Mangifera
        indica, has demonstrated potent antioxidant, anti-inflammatory, and cytoprotective properties in various experimental
        models. This study aims to evaluate the protective effect of mangiferin against BPA-induced cellular and systemic
        toxicity in vitro.
        Methods: The cytotoxic effect of siramesine on endothelial cells (HUVEC) was examined with the SRB. HUVEC cells
        were exposed to Bisphenol A (BPA) at concentrations ranging from 10 to 100 μM. This exposure was conducted in the
        presence or absence of Mangiferin, a compound that was administered at concentrations ranging from 10 to 100 μM.
        Human Umbilical Vein Endothelial Cell (HUVEC) cells were exposed to bisphenol A (BPA) at concentrations of 5, 45 and
        90 μM, 5 μM MNG, and a combination of both, over a 24-48 hour period. This experimental approach was adopted for
        cell cycle analysis and wound healing assay. The primary objective of this investigation was to ascertain the protective
        effect of MNG.
        Results: Mangiferin demonstrated no cytotoxic effect on HUVEC cells within the applied dose range. The investigation
        revealed that the presence of bisphenol A resulted in a dose-dependent enhancement in the degree of cytotoxic effect,
        within the established range of doses. The Bisphenol A GI50 dose was determined to be 88.01 µM, the TGI dose was
        134.34 µM, and the LC50 dose was 179.5 µM. Cell viability increased in the combination of Bisphenol A 90 µM and
        Mangiferin 5 µM. The results of the cell cycle and wound healing experiments provide support for cell viability results.
        Conclusion: Mangiferin is hypothesized to attenuate BPA-induced cell stress, normalize cell behavior, and preserve
        cell integrity. Our results will provide critical insights into the protective efficacy of mangiferin against BPA toxicity and
        contribute to the development of plant-derived interventions for environmental toxicant exposure.





















   154
   164   165   166   167   168   169   170   171   172   173   174